These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1259 related items for PubMed ID: 18288408

  • 1. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H, Iinuma H, Watanabe T.
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [Abstract] [Full Text] [Related]

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Mar; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 3. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A.
    Anticancer Res; 2007 Mar; 27(2):851-6. PubMed ID: 17465211
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J, Adleff V, Hitre E, Pap E, Réti A, Komlósi V, Budai B.
    Magy Onkol; 2007 Mar; 51(2):113-25. PubMed ID: 17660867
    [Abstract] [Full Text] [Related]

  • 5. TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy.
    Tanaka K, Saigusa S, Toiyama Y, Koike Y, Okugawa Y, Yokoe T, Inoue Y, Kobayashi M, Miki C, Kusunoki M.
    J Surg Oncol; 2012 May; 105(6):529-34. PubMed ID: 22006578
    [Abstract] [Full Text] [Related]

  • 6. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4116-24. PubMed ID: 14519634
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of 5-fluorouracil related genes in breast cancer to predict the effect of adjuvant therapy with oral fluorouracil derivatives.
    Tsunoda Y, Suzuki K, Tsunoda A, Takimoto M, Kusano M.
    Oncol Rep; 2010 Mar 15; 23(3):771-7. PubMed ID: 20127019
    [Abstract] [Full Text] [Related]

  • 8. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H, Yamada H, Shirakawa K, Nakada H, Ohsawa T, Takeuchi I, Okada N, Yokoyama M, Inokuma S, Suzuki T, Odaka A, Hoshino T, Murata N, Hashimoto D, Itoyama S, Mori T, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2003 Oct 15; 30(11):1621-6. PubMed ID: 14619479
    [Abstract] [Full Text] [Related]

  • 9. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y, Oka T, Nagayama S, Danenberg PV, Danenberg KD, Fukushima M.
    Int J Mol Med; 2008 Dec 15; 22(6):709-16. PubMed ID: 19020767
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV.
    Clin Cancer Res; 2000 Apr 15; 6(4):1322-7. PubMed ID: 10778957
    [Abstract] [Full Text] [Related]

  • 14. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H, Shirakawa K, Ohsawa T, Sobajima J, Hayashi Y, Nakada H, Yokoyama M, Hashimoto D.
    Gan To Kagaku Ryoho; 2005 Nov 15; 32(12):1929-34. PubMed ID: 16282729
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C, Aust DE, Meyer W, Baretton GB, Schwabe W, Häusler P, Becker H, Liersch T.
    J Pathol; 2004 Dec 15; 204(5):562-8. PubMed ID: 15538739
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T, Ohue M, Takii Y, Hashizume T, Kato T, Kotake K, Sato T, Tango T.
    Oncol Rep; 2013 Feb 15; 29(2):437-44. PubMed ID: 23232805
    [Abstract] [Full Text] [Related]

  • 19. Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy.
    Tateishi Y, Tatemoto Y, Ohno S, Morishita K, Ueta E, Yamamoto T.
    Cancer Lett; 2009 Feb 18; 274(2):187-93. PubMed ID: 18986760
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer.
    Oi K, Makino M, Ozaki M, Takemoto H, Yamane N, Nakamura S, Ikeguchi M, Kaibara N.
    Anticancer Res; 2004 Feb 18; 24(1):273-9. PubMed ID: 15015608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.